Nebulized ivermectin for COVID‑19 and other respiratory diseases, a proof of concept, dose‑ranging study in rats

Nebulized ivermectin for COVID‑19 and other respiratory diseases, a proof of concept, dose‑ranging study in rats

Show other versions (1)

Ivermectin is a widely used antiparasitic drug with known efficacy against several single-strain RNA viruses. Recent data shows significant reduction of SARS-CoV-2 replication in vitro by ivermectin concentrations not achievable with safe doses orally. Inhaled therapy has been used with success for...

Full description

Bibliographic Details
Main Authors: Chaccour, C.J. (Carlos J.), Abizanda-Sarasa, G. (Gloria), Irigoyen-Barrio, A. (Angel), Casellas, A. (Aina), Aldaz, A. (Azucena), Martinez-Galan, F. (Fernando), Hammann, F. (Felix), Gil, A.G. (Ana Gloria)
Format: info:eu-repo/semantics/article
Language:eng
Published: Springer Link 2024
Subjects:
Ivermectin
Antiparasitic drug
RNA viruses
SARS-CoV-2
Online Access:https://hdl.handle.net/10171/68402

Internet

https://hdl.handle.net/10171/68402

Similar Items